Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
Sponsor: AbbVie (prior sponsor, Abbott)
This observational or N/A phase trial investigates Psoriasis and is currently completed. AbbVie (prior sponsor, Abbott) leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed
-
Jan 2020 — Jan 2021 [monthly]
Completed
-
Aug 2018 — Jan 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2018 [monthly]
Active Not Recruiting NA
First recorded
Aug 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AbbVie (prior sponsor, Abbott)
- Cato Research
- JSS Medical Research Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Barrie, Canada, Bathurst, Canada, Brandon, Canada, Calgary, Canada, Drummondville, Canada, Edmonton, Canada, Etobicoke, Canada, Fredericton, Canada, Greater Sudbury, Canada, Halifax, Canada and 21 more location s